Skip to main content
Erschienen in: Immunologic Research 1-3/2012

01.12.2012 | Immunology at Mount Sinai

Delineating the autoimmune mechanisms in Graves’ disease

verfasst von: Syed A. Morshed, Rauf Latif, Terry F. Davies

Erschienen in: Immunologic Research | Ausgabe 1-3/2012

Einloggen, um Zugang zu erhalten

Abstract

The immunologic processes involved in autoimmune thyroid disease (AITD), particularly Graves’ disease (GD), are similar to other autoimmune diseases with the emphasis on the antibodies as the most unique aspect. These characteristics include a lymphocytic infiltrate at the target organs, the presence of antigen-reactive T and B cells and antibodies, and the establishment of animal models of GD by antibody transfer or immunization with antigen. Similar to other autoimmune diseases, risk factors for GD include the presence of multiple susceptibility genes, including certain HLA alleles, and the TSHR gene itself. In addition, a variety of known risk factors and precipitators have been characterized including the influence of sex and sex hormones, pregnancy, stress, infection, iodine and other potential environmental factors. The pathogenesis of GD is likely the result of a breakdown in the tolerance mechanisms, both at central and peripheral levels. Different subsets of T and B cells together with their regulatory populations play important roles in the propagation and maintenance of the disease process. Understanding different mechanistic in the complex system biology interplay will help to identify unique factors contributing to the AITD pathogenesis.
Literatur
1.
Zurück zum Zitat Adams DD, Purves HD. Abnormal responses in the assay of thyrotropin. Proc Univ Otago Med School. 1956;34:11–2. Adams DD, Purves HD. Abnormal responses in the assay of thyrotropin. Proc Univ Otago Med School. 1956;34:11–2.
2.
Zurück zum Zitat Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995;43(1):55–68. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995;43(1):55–68.
3.
Zurück zum Zitat McIver B, Morris JC. The pathogenesis of Graves’ disease. Endocrinol Metab Clin North Am. 1998;27(1):73–89.CrossRefPubMed McIver B, Morris JC. The pathogenesis of Graves’ disease. Endocrinol Metab Clin North Am. 1998;27(1):73–89.CrossRefPubMed
4.
Zurück zum Zitat Bahn RS, Heufelder AE. Pathogenesis of Graves’ ophthalmopathy. N Engl J Med. 1993;329(20):1468–75.CrossRefPubMed Bahn RS, Heufelder AE. Pathogenesis of Graves’ ophthalmopathy. N Engl J Med. 1993;329(20):1468–75.CrossRefPubMed
5.
Zurück zum Zitat LiVolsi VA. The pathology of autoimmune thyroid disease: a review. Thyroid. 1994;4(3):333–9.CrossRefPubMed LiVolsi VA. The pathology of autoimmune thyroid disease: a review. Thyroid. 1994;4(3):333–9.CrossRefPubMed
6.
Zurück zum Zitat Rees SB, McLachlan SM, Furmaniak J. Autoantibodies to the thyrotropin receptor. Endocr Rev. 1988;9(1):106–21.CrossRef Rees SB, McLachlan SM, Furmaniak J. Autoantibodies to the thyrotropin receptor. Endocr Rev. 1988;9(1):106–21.CrossRef
7.
Zurück zum Zitat Witebsky E, Rose NR, Terplan K, Paine JR, Egan RW. Chronic thyroiditis and autoimmunization. J Am Med Assoc. 1957;164(13):1439–47. Epub 1957/07/27. Witebsky E, Rose NR, Terplan K, Paine JR, Egan RW. Chronic thyroiditis and autoimmunization. J Am Med Assoc. 1957;164(13):1439–47. Epub 1957/07/27.
8.
Zurück zum Zitat Tomer Y. Genetic susceptibility to autoimmune thyroid disease: past, present, and future. Thyroid. 2010;20(7):715–25. Epub 2010/07/08. Tomer Y. Genetic susceptibility to autoimmune thyroid disease: past, present, and future. Thyroid. 2010;20(7):715–25. Epub 2010/07/08.
9.
Zurück zum Zitat Tomer Y, Menconi F, Davies TF, Barbesino G, Rocchi R, Pinchera A, et al. Dissecting genetic heterogeneity in autoimmune thyroid diseases by subset analysis. J Autoimmun. 2007;29(2–3):69–77.CrossRefPubMed Tomer Y, Menconi F, Davies TF, Barbesino G, Rocchi R, Pinchera A, et al. Dissecting genetic heterogeneity in autoimmune thyroid diseases by subset analysis. J Autoimmun. 2007;29(2–3):69–77.CrossRefPubMed
10.
Zurück zum Zitat Jacobson EM, Tomer Y. The genetic basis of thyroid autoimmunity. Thyroid. 2007;17(10):949–61. Epub 2007/09/11. Jacobson EM, Tomer Y. The genetic basis of thyroid autoimmunity. Thyroid. 2007;17(10):949–61. Epub 2007/09/11.
11.
Zurück zum Zitat Davies TF. Infection and autoimmune thyroid disease. J Clin Endocrinol Metab. 2008;93(3):674–6.CrossRefPubMed Davies TF. Infection and autoimmune thyroid disease. J Clin Endocrinol Metab. 2008;93(3):674–6.CrossRefPubMed
12.
Zurück zum Zitat Ladygina N, Martin BR, Altman A. Dynamic palmitoylation and the role of DHHC proteins in T cell activation and anergy. Adv Immunol. 2011;109:1–44. Epub 2011/05/17. Ladygina N, Martin BR, Altman A. Dynamic palmitoylation and the role of DHHC proteins in T cell activation and anergy. Adv Immunol. 2011;109:1–44. Epub 2011/05/17.
13.
Zurück zum Zitat Meffre E, Wardemann H. B-cell tolerance checkpoints in health and autoimmunity. Curr Opin Immunol. 2008;20(6):632–8.CrossRefPubMed Meffre E, Wardemann H. B-cell tolerance checkpoints in health and autoimmunity. Curr Opin Immunol. 2008;20(6):632–8.CrossRefPubMed
14.
Zurück zum Zitat Latrofa F, Ricci D, Grasso L, Vitti P, Masserini L, Basolo F, et al. Characterization of thyroglobulin epitopes in patients with autoimmune and non-autoimmune thyroid diseases using recombinant human monoclonal thyroglobulin autoantibodies. J Clin Endocrinol Metab. 2008;93(2):591–6. Epub 2007/11/22. Latrofa F, Ricci D, Grasso L, Vitti P, Masserini L, Basolo F, et al. Characterization of thyroglobulin epitopes in patients with autoimmune and non-autoimmune thyroid diseases using recombinant human monoclonal thyroglobulin autoantibodies. J Clin Endocrinol Metab. 2008;93(2):591–6. Epub 2007/11/22.
15.
Zurück zum Zitat Rebuffat SA, Nguyen B, Robert B, Castex F, Peraldi-Roux S. Antithyroperoxidase antibody-dependent cytotoxicity in autoimmune thyroid disease. J Clin Endocrinol Metab. 2008;93(3):929–34. Epub 2007/12/13. Rebuffat SA, Nguyen B, Robert B, Castex F, Peraldi-Roux S. Antithyroperoxidase antibody-dependent cytotoxicity in autoimmune thyroid disease. J Clin Endocrinol Metab. 2008;93(3):929–34. Epub 2007/12/13.
16.
Zurück zum Zitat Kohno Y, Naito N, Hiyama Y, Shimojo N, Suzuki N, Tarutani O, et al. Thyroglobulin and thyroid peroxidase share common epitopes recognized by autoantibodies in patients with chronic autoimmune thyroiditis. J Clin Endocrinol Metab. 1988;67(5):899–907. Epub 1988/11/01. Kohno Y, Naito N, Hiyama Y, Shimojo N, Suzuki N, Tarutani O, et al. Thyroglobulin and thyroid peroxidase share common epitopes recognized by autoantibodies in patients with chronic autoimmune thyroiditis. J Clin Endocrinol Metab. 1988;67(5):899–907. Epub 1988/11/01.
17.
Zurück zum Zitat Latrofa F, Pichurin P, Guo J, Rapoport B, McLachlan SM. Thyroglobulin-thyroperoxidase autoantibodies are polyreactive, not bispecific: analysis using human monoclonal autoantibodies. J Clin Endocrinol Metab. 2003;88(1):371–8. Epub 2003/01/10. Latrofa F, Pichurin P, Guo J, Rapoport B, McLachlan SM. Thyroglobulin-thyroperoxidase autoantibodies are polyreactive, not bispecific: analysis using human monoclonal autoantibodies. J Clin Endocrinol Metab. 2003;88(1):371–8. Epub 2003/01/10.
18.
Zurück zum Zitat Bahn RS, Dutton CM, Natt N, Joba W, Spitzweg C, Heufelder AE. Thyrotropin receptor expression in Graves’ orbital adipose/connective tissues: potential autoantigen in Graves’ ophthalmopathy. J Clin Endocrinol Metab. 1998;83(3):998–1002.CrossRefPubMed Bahn RS, Dutton CM, Natt N, Joba W, Spitzweg C, Heufelder AE. Thyrotropin receptor expression in Graves’ orbital adipose/connective tissues: potential autoantigen in Graves’ ophthalmopathy. J Clin Endocrinol Metab. 1998;83(3):998–1002.CrossRefPubMed
19.
Zurück zum Zitat Misrahi M, Ghinea N, Sar S, Saunier B, Jolivet A, Loosfelt H, et al. Processing of the precursors of the human thyroid-stimulating hormone receptor in various eukaryotic cells (human thyrocytes, transfected L cells and baculovirus-infected insect cells). Eur J Biochem. 1994;222(2):711–9.CrossRefPubMed Misrahi M, Ghinea N, Sar S, Saunier B, Jolivet A, Loosfelt H, et al. Processing of the precursors of the human thyroid-stimulating hormone receptor in various eukaryotic cells (human thyrocytes, transfected L cells and baculovirus-infected insect cells). Eur J Biochem. 1994;222(2):711–9.CrossRefPubMed
20.
Zurück zum Zitat Chazenbalk GD, Pichurin P, Chen CR, Latrofa F, Johnstone AP, McLachlan SM, et al. Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor. J Clin Invest. 2002;110(2):209–17.PubMed Chazenbalk GD, Pichurin P, Chen CR, Latrofa F, Johnstone AP, McLachlan SM, et al. Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor. J Clin Invest. 2002;110(2):209–17.PubMed
21.
Zurück zum Zitat Kajita Y, Rickards CR, Buckland PR, Howells RD, Rees SB. Analysis of thyrotropin receptors by photoaffinity labelling. Orientation of receptor subunits in the cell membrane. Biochem J. 1985;227(2):413–20. Kajita Y, Rickards CR, Buckland PR, Howells RD, Rees SB. Analysis of thyrotropin receptors by photoaffinity labelling. Orientation of receptor subunits in the cell membrane. Biochem J. 1985;227(2):413–20.
22.
Zurück zum Zitat Loosfelt H, Pichon C, Jolivet A, Misrahi M, Caillou B, Jamous M, et al. Two-subunit structure of the human thyrotropin receptor. Proc Natl Acad Sci USA. 1992;89(9):3765–9.CrossRefPubMed Loosfelt H, Pichon C, Jolivet A, Misrahi M, Caillou B, Jamous M, et al. Two-subunit structure of the human thyrotropin receptor. Proc Natl Acad Sci USA. 1992;89(9):3765–9.CrossRefPubMed
23.
Zurück zum Zitat Latif R, Morshed SA, Zaidi M, Davies TF. The thyroid-stimulating hormone receptor: impact of thyroid-stimulating hormone and thyroid-stimulating hormone receptor antibodies on multimerization, cleavage, and signaling. Endocrinol Metab Clin North Am. 2009;38(2):319–41.CrossRefPubMed Latif R, Morshed SA, Zaidi M, Davies TF. The thyroid-stimulating hormone receptor: impact of thyroid-stimulating hormone and thyroid-stimulating hormone receptor antibodies on multimerization, cleavage, and signaling. Endocrinol Metab Clin North Am. 2009;38(2):319–41.CrossRefPubMed
24.
Zurück zum Zitat Davies TF, Ando T, Lin RY, Tomer Y, Latif R. Thyrotropin receptor-associated diseases: from adenomata to Graves disease. J Clin Invest. 2005;115(8):1972–83.CrossRefPubMed Davies TF, Ando T, Lin RY, Tomer Y, Latif R. Thyrotropin receptor-associated diseases: from adenomata to Graves disease. J Clin Invest. 2005;115(8):1972–83.CrossRefPubMed
25.
Zurück zum Zitat Vlase H, Davies TF. Insights into the molecular mechanisms of the autoimmune thyroid diseases. In: Eisenbarth GS editor. Endocrine and organ specific autoimmunity. CA: R.G. Landes Co.; 1999. pp. 98–132. Vlase H, Davies TF. Insights into the molecular mechanisms of the autoimmune thyroid diseases. In: Eisenbarth GS editor. Endocrine and organ specific autoimmunity. CA: R.G. Landes Co.; 1999. pp. 98–132.
26.
Zurück zum Zitat Lipsky PE. Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity. Nat Immunol. 2001;2(9):764–6.CrossRefPubMed Lipsky PE. Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity. Nat Immunol. 2001;2(9):764–6.CrossRefPubMed
27.
Zurück zum Zitat De Groot LJ, Shin YH, Pan D, Gopalakrishnan G, Hennessey JV. Evaluation of T cell stimulation by thyrotropin-receptor epitopes in Graves’ disease. J Endocrinol Invest. 2009;32(1):52–6. Epub 2009/04/02. De Groot LJ, Shin YH, Pan D, Gopalakrishnan G, Hennessey JV. Evaluation of T cell stimulation by thyrotropin-receptor epitopes in Graves’ disease. J Endocrinol Invest. 2009;32(1):52–6. Epub 2009/04/02.
28.
Zurück zum Zitat Caturegli P, Kimura H, Rocchi R, Rose NR. Autoimmune thyroid disease. Curr Opin Rheumatol. 2007;19(1):44–8.CrossRefPubMed Caturegli P, Kimura H, Rocchi R, Rose NR. Autoimmune thyroid disease. Curr Opin Rheumatol. 2007;19(1):44–8.CrossRefPubMed
29.
Zurück zum Zitat Ando T, Davies TF. Monoclonal antibodies to the thyrotropin receptor. Clin Dev Immunol. 2005;12(2):137–43.CrossRefPubMed Ando T, Davies TF. Monoclonal antibodies to the thyrotropin receptor. Clin Dev Immunol. 2005;12(2):137–43.CrossRefPubMed
30.
Zurück zum Zitat Ando T, Latif R, Pritsker A, Moran T, Nagayama Y, Davies TF. A monoclonal thyroid-stimulating antibody. J Clin Invest. 2002;110(11):1667–74.PubMed Ando T, Latif R, Pritsker A, Moran T, Nagayama Y, Davies TF. A monoclonal thyroid-stimulating antibody. J Clin Invest. 2002;110(11):1667–74.PubMed
31.
Zurück zum Zitat Ando T, Latif R, Davies TF. Antibody-induced modulation of TSH receptor post-translational processing. J Endocrinol. 2007;195(1):179–86.CrossRefPubMed Ando T, Latif R, Davies TF. Antibody-induced modulation of TSH receptor post-translational processing. J Endocrinol. 2007;195(1):179–86.CrossRefPubMed
32.
Zurück zum Zitat Morshed SA, Latif R, Davies TF. Characterization of thyrotropin receptor antibody-induced signaling cascades. Endocrinology. 2009;150(1):519–29.CrossRefPubMed Morshed SA, Latif R, Davies TF. Characterization of thyrotropin receptor antibody-induced signaling cascades. Endocrinology. 2009;150(1):519–29.CrossRefPubMed
33.
Zurück zum Zitat Ando T, Latif R, Daniel S, Eguchi K, Davies TF. Dissecting linear and conformational epitopes on the native thyrotropin receptor. Endocrinology. 2004;145(11):5185–93.CrossRefPubMed Ando T, Latif R, Daniel S, Eguchi K, Davies TF. Dissecting linear and conformational epitopes on the native thyrotropin receptor. Endocrinology. 2004;145(11):5185–93.CrossRefPubMed
34.
Zurück zum Zitat Davies TF, Bobovnikova Y, Weiss M, Vlase H, Moran T, Graves PN. Development and characterization of monoclonal antibodies specific for the murine thyrotropin receptor. Thyroid. 1998;8(8):693–701.CrossRefPubMed Davies TF, Bobovnikova Y, Weiss M, Vlase H, Moran T, Graves PN. Development and characterization of monoclonal antibodies specific for the murine thyrotropin receptor. Thyroid. 1998;8(8):693–701.CrossRefPubMed
35.
Zurück zum Zitat Sanders J, Jeffreys J, Depraetere H, Evans M, Richards T, Kiddie A, et al. Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function. Thyroid. 2004;14(8):560–70.CrossRefPubMed Sanders J, Jeffreys J, Depraetere H, Evans M, Richards T, Kiddie A, et al. Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function. Thyroid. 2004;14(8):560–70.CrossRefPubMed
36.
Zurück zum Zitat Nagy EV, Burch HB, Mahoney K, Lukes YG, Morris JC III, Burman KD. Graves’ IgG recognizes linear epitopes in the human thyrotropin receptor. Biochem Biophys Res Commun. 1992;188(1):28–33.CrossRefPubMed Nagy EV, Burch HB, Mahoney K, Lukes YG, Morris JC III, Burman KD. Graves’ IgG recognizes linear epitopes in the human thyrotropin receptor. Biochem Biophys Res Commun. 1992;188(1):28–33.CrossRefPubMed
37.
Zurück zum Zitat Sanders J, Chirgadze DY, Sanders P, Baker S, Sullivan A, Bhardwaja A, et al. Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody. Thyroid. 2007;17(5):395–410.CrossRefPubMed Sanders J, Chirgadze DY, Sanders P, Baker S, Sullivan A, Bhardwaja A, et al. Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody. Thyroid. 2007;17(5):395–410.CrossRefPubMed
38.
Zurück zum Zitat Sanders J, Bolton J, Sanders P, Jeffreys J, Nakatake N, Richards T, et al. Effects of TSH receptor mutations on binding and biological activity of monoclonal antibodies and TSH. Thyroid. 2006;16(12):1195–206.CrossRefPubMed Sanders J, Bolton J, Sanders P, Jeffreys J, Nakatake N, Richards T, et al. Effects of TSH receptor mutations on binding and biological activity of monoclonal antibodies and TSH. Thyroid. 2006;16(12):1195–206.CrossRefPubMed
39.
Zurück zum Zitat Latif R, Michalek, K, Teixeira, A, Davies TF. Protecting TSH receptor antibody binding pockets reveals both leucine rich repeats and non-leucine rich domains. 81st Annual Meeting of the American Thyroid Association; CA, USA. 2011. Latif R, Michalek, K, Teixeira, A, Davies TF. Protecting TSH receptor antibody binding pockets reveals both leucine rich repeats and non-leucine rich domains. 81st Annual Meeting of the American Thyroid Association; CA, USA. 2011.
40.
Zurück zum Zitat Morshed SA, Latif R, Davies TF. TSHR antibodies induce fibroblast proliferation and apoptosis: implications for Graves’ disease. 81st Annual Meeting of the American Thyroid Association; CA, USA. 2011. Morshed SA, Latif R, Davies TF. TSHR antibodies induce fibroblast proliferation and apoptosis: implications for Graves’ disease. 81st Annual Meeting of the American Thyroid Association; CA, USA. 2011.
41.
Zurück zum Zitat Minich WB, Lenzner C, Morgenthaler NG. Antibodies to TSH-receptor in thyroid autoimmune disease interact with monoclonal antibodies whose epitopes are broadly distributed on the receptor. Clin Exp Immunol. 2004;136(1):129–36.CrossRefPubMed Minich WB, Lenzner C, Morgenthaler NG. Antibodies to TSH-receptor in thyroid autoimmune disease interact with monoclonal antibodies whose epitopes are broadly distributed on the receptor. Clin Exp Immunol. 2004;136(1):129–36.CrossRefPubMed
42.
Zurück zum Zitat Sanders J, Jeffreys J, Depraetere H, Richards T, Evans M, Kiddie A, et al. Thyroid-stimulating monoclonal antibodies. Thyroid. 2002;12(12):1043–50.CrossRefPubMed Sanders J, Jeffreys J, Depraetere H, Richards T, Evans M, Kiddie A, et al. Thyroid-stimulating monoclonal antibodies. Thyroid. 2002;12(12):1043–50.CrossRefPubMed
43.
Zurück zum Zitat Schwarz-Lauer L, Pichurin PN, Chen CR, Nagayama Y, Paras C, Morris JC, et al. The cysteine-rich amino terminus of the thyrotropin receptor is the immunodominant linear antibody epitope in mice immunized using naked deoxyribonucleic acid or adenovirus vectors. Endocrinology. 2003;144(5):1718–25.CrossRefPubMed Schwarz-Lauer L, Pichurin PN, Chen CR, Nagayama Y, Paras C, Morris JC, et al. The cysteine-rich amino terminus of the thyrotropin receptor is the immunodominant linear antibody epitope in mice immunized using naked deoxyribonucleic acid or adenovirus vectors. Endocrinology. 2003;144(5):1718–25.CrossRefPubMed
44.
Zurück zum Zitat Ando T, Latif R, Davies TF. Concentration-dependent regulation of thyrotropin receptor function by thyroid-stimulating antibody. J Clin Invest. 2004;113(11):1589–95.PubMed Ando T, Latif R, Davies TF. Concentration-dependent regulation of thyrotropin receptor function by thyroid-stimulating antibody. J Clin Invest. 2004;113(11):1589–95.PubMed
45.
Zurück zum Zitat Minich WB, Loos U. Detection of functionally different types of pathological autoantibodies against thyrotropin receptor in Graves’ patients sera by luminescent immunoprecipitation analysis. Exp Clin Endocrinol Diabetes. 2000;108(2):110–9.CrossRefPubMed Minich WB, Loos U. Detection of functionally different types of pathological autoantibodies against thyrotropin receptor in Graves’ patients sera by luminescent immunoprecipitation analysis. Exp Clin Endocrinol Diabetes. 2000;108(2):110–9.CrossRefPubMed
46.
Zurück zum Zitat Kakinuma A, Chazenbalk GD, Tanaka K, Nagayama Y, McLachlan SM, Rapoport B. An N-linked glycosylation motif from the noncleaving luteinizing hormone receptor substituted for the homologous region (Gly367 to Glu369) of the thyrotropin receptor prevents cleavage at its second, downstream site. J Biol Chem. 1997;272(45):28296–300.CrossRefPubMed Kakinuma A, Chazenbalk GD, Tanaka K, Nagayama Y, McLachlan SM, Rapoport B. An N-linked glycosylation motif from the noncleaving luteinizing hormone receptor substituted for the homologous region (Gly367 to Glu369) of the thyrotropin receptor prevents cleavage at its second, downstream site. J Biol Chem. 1997;272(45):28296–300.CrossRefPubMed
47.
Zurück zum Zitat Sanders P, Young S, Sanders J, Kabelis K, Baker S, Sullivan A, et al. Crystal structure of the TSH receptor (TSHR) bound to a blocking-type TSHR autoantibody. J Mol Endocrinol. 2011;46(2):81–99. Epub 2011/01/21. Sanders P, Young S, Sanders J, Kabelis K, Baker S, Sullivan A, et al. Crystal structure of the TSH receptor (TSHR) bound to a blocking-type TSHR autoantibody. J Mol Endocrinol. 2011;46(2):81–99. Epub 2011/01/21.
48.
Zurück zum Zitat Costagliola S, Rodien P, Many MC, Ludgate M, Vassart G. Genetic immunization against the human thyrotropin receptor causes thyroiditis and allows production of monoclonal antibodies recognizing the native receptor. J Immunol. 1998;160(3):1458–65.PubMed Costagliola S, Rodien P, Many MC, Ludgate M, Vassart G. Genetic immunization against the human thyrotropin receptor causes thyroiditis and allows production of monoclonal antibodies recognizing the native receptor. J Immunol. 1998;160(3):1458–65.PubMed
49.
Zurück zum Zitat Nagayama Y, Kita-Furuyama M, Ando T, Nakao K, Mizuguchi H, Hayakawa T, et al. A novel murine model of Graves’ hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor. J Immunol. 2002;168(6):2789–94.PubMed Nagayama Y, Kita-Furuyama M, Ando T, Nakao K, Mizuguchi H, Hayakawa T, et al. A novel murine model of Graves’ hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor. J Immunol. 2002;168(6):2789–94.PubMed
50.
Zurück zum Zitat Jeffreys J, Depraetere H, Sanders J, Oda Y, Evans M, Kiddie A, et al. Characterization of the thyrotropin binding pocket. Thyroid. 2002;12(12):1051–61.CrossRefPubMed Jeffreys J, Depraetere H, Sanders J, Oda Y, Evans M, Kiddie A, et al. Characterization of the thyrotropin binding pocket. Thyroid. 2002;12(12):1051–61.CrossRefPubMed
51.
Zurück zum Zitat Gilbert JA, Kalled SL, Moorhead J, Hess DM, Rennert P, Li Z, et al. Treatment of autoimmune hyperthyroidism in a murine model of Graves’ disease with tumor necrosis factor-family ligand inhibitors suggests a key role for B cell activating factor in disease pathology. Endocrinology. 2006;147(10):4561–8.CrossRefPubMed Gilbert JA, Kalled SL, Moorhead J, Hess DM, Rennert P, Li Z, et al. Treatment of autoimmune hyperthyroidism in a murine model of Graves’ disease with tumor necrosis factor-family ligand inhibitors suggests a key role for B cell activating factor in disease pathology. Endocrinology. 2006;147(10):4561–8.CrossRefPubMed
52.
Zurück zum Zitat Lai Kwan LQ, King Hung KO, Zheng BJ, Lu L. Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis. Proc Natl Acad Sci USA. 2008;105(39):14993–8. Lai Kwan LQ, King Hung KO, Zheng BJ, Lu L. Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis. Proc Natl Acad Sci USA. 2008;105(39):14993–8.
53.
Zurück zum Zitat Salvi M, Vannucchi G, Campi I, Rossi S, Bonara P, Sbrozzi F, et al. Efficacy of rituximab treatment for thyroid-associated ophthalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosuppression. Eur J Endocrinol. 2006;154(4):511–7.CrossRefPubMed Salvi M, Vannucchi G, Campi I, Rossi S, Bonara P, Sbrozzi F, et al. Efficacy of rituximab treatment for thyroid-associated ophthalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosuppression. Eur J Endocrinol. 2006;154(4):511–7.CrossRefPubMed
54.
Zurück zum Zitat Chen CR, McLachlan SM, Rapoport B. Suppression of thyrotropin receptor constitutive activity by a monoclonal antibody with inverse agonist activity. Endocrinology. 2007;148(5):2375–82.CrossRefPubMed Chen CR, McLachlan SM, Rapoport B. Suppression of thyrotropin receptor constitutive activity by a monoclonal antibody with inverse agonist activity. Endocrinology. 2007;148(5):2375–82.CrossRefPubMed
55.
Zurück zum Zitat Stassi G, De MR. Autoimmune thyroid disease: new models of cell death in autoimmunity. Nat Rev Immunol. 2002;2(3):195–204.CrossRefPubMed Stassi G, De MR. Autoimmune thyroid disease: new models of cell death in autoimmunity. Nat Rev Immunol. 2002;2(3):195–204.CrossRefPubMed
56.
Zurück zum Zitat Wang SH, Baker JR. The role of apoptosis in thyroid autoimmunity. Thyroid. 2007;17(10):975–9. Epub 2007/09/29. Wang SH, Baker JR. The role of apoptosis in thyroid autoimmunity. Thyroid. 2007;17(10):975–9. Epub 2007/09/29.
57.
Zurück zum Zitat Mao C, Wang S, Xiao Y, Xu J, Jiang Q, Jin M, et al. Impairment of regulatory capacity of CD4+ CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves’ disease. J Immunol. 2011;186(8):4734–43. Epub 2011/03/15. Mao C, Wang S, Xiao Y, Xu J, Jiang Q, Jin M, et al. Impairment of regulatory capacity of CD4+ CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves’ disease. J Immunol. 2011;186(8):4734–43. Epub 2011/03/15.
58.
Zurück zum Zitat Bossowski A, Czarnocka B, Bardadin K, Stasiak-Barmuta A, Urban M, Dadan J, et al. Identification of apoptotic proteins in thyroid gland from patients with Graves’ disease and Hashimoto’s thyroiditis. Autoimmunity. 2008;41(2):163–73. Epub 2008/03/08. Bossowski A, Czarnocka B, Bardadin K, Stasiak-Barmuta A, Urban M, Dadan J, et al. Identification of apoptotic proteins in thyroid gland from patients with Graves’ disease and Hashimoto’s thyroiditis. Autoimmunity. 2008;41(2):163–73. Epub 2008/03/08.
59.
Zurück zum Zitat Bossowski A, Czarnocka B, Bardadin K, Urban M, Niedziela M, Dadan J. Expression of Bcl-2 family proteins in thyrocytes from young patients with immune and nonimmune thyroid diseases. Horm Res. 2008;70(3):155–64. Epub 2008/07/30. Bossowski A, Czarnocka B, Bardadin K, Urban M, Niedziela M, Dadan J. Expression of Bcl-2 family proteins in thyrocytes from young patients with immune and nonimmune thyroid diseases. Horm Res. 2008;70(3):155–64. Epub 2008/07/30.
60.
Zurück zum Zitat Newby PR, Roberts-Davies EL, Brand OJ, Heward JM, Franklyn JA, Gough SCL, et al. Tag SNP screening of the PDCD1 gene for association with Graves’ disease. Clin Endocrinol. 2007;67(1):125–8.CrossRef Newby PR, Roberts-Davies EL, Brand OJ, Heward JM, Franklyn JA, Gough SCL, et al. Tag SNP screening of the PDCD1 gene for association with Graves’ disease. Clin Endocrinol. 2007;67(1):125–8.CrossRef
61.
Zurück zum Zitat Morshed SA, Ando T, Latif R, Davies TF. Neutral antibodies to the TSH receptor are present in Graves’ disease and regulate selective signaling cascades. Endocrinology. 2010;151(11):5537–49. Epub 2010/09/17. Morshed SA, Ando T, Latif R, Davies TF. Neutral antibodies to the TSH receptor are present in Graves’ disease and regulate selective signaling cascades. Endocrinology. 2010;151(11):5537–49. Epub 2010/09/17.
62.
Zurück zum Zitat Kawashima A, Tanigawa K, Akama T, Wu H, Sue M, Yoshihara A, et al. Fragments of genomic DNA released by injured cells activate innate immunity and suppress endocrine function in the thyroid. Endocrinology. 2011;152(4):1702–12. Epub 2011/02/10. Kawashima A, Tanigawa K, Akama T, Wu H, Sue M, Yoshihara A, et al. Fragments of genomic DNA released by injured cells activate innate immunity and suppress endocrine function in the thyroid. Endocrinology. 2011;152(4):1702–12. Epub 2011/02/10.
63.
Zurück zum Zitat Nakamura H, Usa T, Motomura M, Ichikawa T, Nakao K, Kawasaki E, et al. Prevalence of interrelated autoantibodies in thyroid diseases and autoimmune disorders. J Endocrinol Invest. 2008;31(10):861–5.PubMed Nakamura H, Usa T, Motomura M, Ichikawa T, Nakao K, Kawasaki E, et al. Prevalence of interrelated autoantibodies in thyroid diseases and autoimmune disorders. J Endocrinol Invest. 2008;31(10):861–5.PubMed
64.
Zurück zum Zitat Endo T, Kogai T, Nakazato M, Saito T, Kaneshige M, Onaya T. Autoantibody against Na+/I- symporter in the sera of patients with autoimmune thyroid disease. Biochem Biophys Res Commun. 1996;224(1):92–5.CrossRefPubMed Endo T, Kogai T, Nakazato M, Saito T, Kaneshige M, Onaya T. Autoantibody against Na+/I- symporter in the sera of patients with autoimmune thyroid disease. Biochem Biophys Res Commun. 1996;224(1):92–5.CrossRefPubMed
65.
Zurück zum Zitat Yoshida A, Hisatome I, Taniguchi S, Shirayoshi Y, Yamamoto Y, Miake J, et al. Pendrin is a novel autoantigen recognized by patients with autoimmune thyroid diseases. J Clin Endocrinol Metab. 2009;94(2):442–8.CrossRefPubMed Yoshida A, Hisatome I, Taniguchi S, Shirayoshi Y, Yamamoto Y, Miake J, et al. Pendrin is a novel autoantigen recognized by patients with autoimmune thyroid diseases. J Clin Endocrinol Metab. 2009;94(2):442–8.CrossRefPubMed
66.
Zurück zum Zitat Benvenga S, Trimarchi F, Robbins J. Circulating thyroid hormone autoantibodies. J Endocrinol Invest. 1987;10(6):605–19. Epub 1987/12/01. Benvenga S, Trimarchi F, Robbins J. Circulating thyroid hormone autoantibodies. J Endocrinol Invest. 1987;10(6):605–19. Epub 1987/12/01.
67.
Zurück zum Zitat Tachi J, Amino N, Tamaki H, Aozasa M, Iwatani Y, Miyai K. Long term follow-up and HLA association in patients with postpartum hypothyroidism. J Clin Endocrinol Metab. 1988;66(3):480–4. Epub 1988/03/01. Tachi J, Amino N, Tamaki H, Aozasa M, Iwatani Y, Miyai K. Long term follow-up and HLA association in patients with postpartum hypothyroidism. J Clin Endocrinol Metab. 1988;66(3):480–4. Epub 1988/03/01.
68.
Zurück zum Zitat Katakura M, Yamada T, Aizawa T, Hiramatsu K, Yukimura Y, Ishihara M, et al. Presence of antideoxyribonucleic acid antibody in patients with hyperthyroidism of Graves’ disease. J Clin Endocrinol Metab. 1987;64(3):405–8. Epub 1987/03/01. Katakura M, Yamada T, Aizawa T, Hiramatsu K, Yukimura Y, Ishihara M, et al. Presence of antideoxyribonucleic acid antibody in patients with hyperthyroidism of Graves’ disease. J Clin Endocrinol Metab. 1987;64(3):405–8. Epub 1987/03/01.
69.
Zurück zum Zitat Marino M, Chiovato L, Friedlander JA, Latrofa F, Pinchera A, McCluskey RT. Serum antibodies against megalin (GP330) in patients with autoimmune thyroiditis. J Clin Endocrinol Metab. 1999;84(7):2468–74. Epub 1999/07/15. Marino M, Chiovato L, Friedlander JA, Latrofa F, Pinchera A, McCluskey RT. Serum antibodies against megalin (GP330) in patients with autoimmune thyroiditis. J Clin Endocrinol Metab. 1999;84(7):2468–74. Epub 1999/07/15.
70.
Zurück zum Zitat Douglas RS, Naik V, Hwang CJ, Afifiyan NF, Gianoukakis AG, Sand D, et al. B cells from patients with Graves’ disease aberrantly express the IGF-1 receptor: implications for disease pathogenesis. J Immunol. 2008;181(8):5768–74.PubMed Douglas RS, Naik V, Hwang CJ, Afifiyan NF, Gianoukakis AG, Sand D, et al. B cells from patients with Graves’ disease aberrantly express the IGF-1 receptor: implications for disease pathogenesis. J Immunol. 2008;181(8):5768–74.PubMed
71.
Zurück zum Zitat Smith TJ. Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases? Pharmacol Rev. 2010;62(2):199–236. Epub 2010/04/16. Smith TJ. Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases? Pharmacol Rev. 2010;62(2):199–236. Epub 2010/04/16.
72.
Zurück zum Zitat Davies TF, Yin X, Latif R. The genetics of the thyroid stimulating hormone receptor: history and relevance. Thyroid. 2010;20(7):727–36. Epub 2010/06/29. Davies TF, Yin X, Latif R. The genetics of the thyroid stimulating hormone receptor: history and relevance. Thyroid. 2010;20(7):727–36. Epub 2010/06/29.
73.
Zurück zum Zitat Kong YC, Flynn JC, Wan Q, David CS. HLA and H2 class II transgenic mouse models to study susceptibility and protection in autoimmune thyroid disease. Autoimmunity. 2003;36(6–7):397–404. Epub 2003/12/13. Kong YC, Flynn JC, Wan Q, David CS. HLA and H2 class II transgenic mouse models to study susceptibility and protection in autoimmune thyroid disease. Autoimmunity. 2003;36(6–7):397–404. Epub 2003/12/13.
74.
Zurück zum Zitat Menconi F, Huber A, Osman R, Concepcion E, Jacobson EM, Stefan M, et al. Tg.2098 is a major human thyroglobulin T-cell epitope. J Autoimmun. 2010;35(1):45–51. Epub 2010/03/23. Menconi F, Huber A, Osman R, Concepcion E, Jacobson EM, Stefan M, et al. Tg.2098 is a major human thyroglobulin T-cell epitope. J Autoimmun. 2010;35(1):45–51. Epub 2010/03/23.
75.
Zurück zum Zitat Ban Y, Tomer Y. The contribution of immune regulatory and thyroid specific genes to the etiology of Graves’ and Hashimoto’s diseases. Autoimmunity. 2003;36(6–7):367–79. Epub 2003/12/13. Ban Y, Tomer Y. The contribution of immune regulatory and thyroid specific genes to the etiology of Graves’ and Hashimoto’s diseases. Autoimmunity. 2003;36(6–7):367–79. Epub 2003/12/13.
76.
Zurück zum Zitat Han S, Zhang S, Zhang W, Li R, Li Y, Wang Z, et al. CTLA4 polymorphisms and ophthalmopathy in Graves’ disease patients: association study and meta-analysis. Hum Immunol. 2006;67(8):618–26. Epub 2006/08/19. Han S, Zhang S, Zhang W, Li R, Li Y, Wang Z, et al. CTLA4 polymorphisms and ophthalmopathy in Graves’ disease patients: association study and meta-analysis. Hum Immunol. 2006;67(8):618–26. Epub 2006/08/19.
77.
Zurück zum Zitat Zhang J, Zahir N, Jiang Q, Miliotis H, Heyraud S, Meng X, et al. The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness. Nat Genet. 2011;43(9):902–7. Epub 2011/08/16. Zhang J, Zahir N, Jiang Q, Miliotis H, Heyraud S, Meng X, et al. The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness. Nat Genet. 2011;43(9):902–7. Epub 2011/08/16.
78.
Zurück zum Zitat Ban Y, Tozaki T, Taniyama M, Tomita M. Association of a C/T single-nucleotide polymorphism in the 5′ untranslated region of the CD40 gene with Graves’ disease in Japanese. Thyroid. 2006;16(5):443–6. Epub 2006/06/08. Ban Y, Tozaki T, Taniyama M, Tomita M. Association of a C/T single-nucleotide polymorphism in the 5′ untranslated region of the CD40 gene with Graves’ disease in Japanese. Thyroid. 2006;16(5):443–6. Epub 2006/06/08.
79.
Zurück zum Zitat Chistiakov DA, Chistiakova EI, Voronova NV, Turakulov RI, Savost’anov KV. A variant of the Il2ra/Cd25 gene predisposing to graves’ disease is associated with increased levels of soluble interleukin-2 receptor. Scand J Immunol. 2011;74(5):496–501. Epub 2011/08/06. Chistiakov DA, Chistiakova EI, Voronova NV, Turakulov RI, Savost’anov KV. A variant of the Il2ra/Cd25 gene predisposing to graves’ disease is associated with increased levels of soluble interleukin-2 receptor. Scand J Immunol. 2011;74(5):496–501. Epub 2011/08/06.
80.
Zurück zum Zitat Simmonds MJ, Heward JM, Carr-Smith J, Foxall H, Franklyn JA, Gough SC. Contribution of single nucleotide polymorphisms within FCRL3 and MAP3K7IP2 to the pathogenesis of Graves’ disease. J Clin Endocrinol Metab. 2006;91(3):1056–61. Epub 2005/12/31. Simmonds MJ, Heward JM, Carr-Smith J, Foxall H, Franklyn JA, Gough SC. Contribution of single nucleotide polymorphisms within FCRL3 and MAP3K7IP2 to the pathogenesis of Graves’ disease. J Clin Endocrinol Metab. 2006;91(3):1056–61. Epub 2005/12/31.
81.
Zurück zum Zitat Ban Y, Greenberg DA, Concepcion E, Skrabanek L, Villanueva R, Tomer Y. Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease. Proc Natl Acad Sci USA. 2003;100(25):15119–24. Epub 2003/12/06. Ban Y, Greenberg DA, Concepcion E, Skrabanek L, Villanueva R, Tomer Y. Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease. Proc Natl Acad Sci USA. 2003;100(25):15119–24. Epub 2003/12/06.
82.
Zurück zum Zitat Yin X, Latif R, Bahn R, Tomer Y, Davies TF. Influence of the TSH receptor gene on susceptibility to Graves’ disease and Graves’ ophthalmopathy. Thyroid. 2008;18(11):1201–6. Epub 2008/10/18. Yin X, Latif R, Bahn R, Tomer Y, Davies TF. Influence of the TSH receptor gene on susceptibility to Graves’ disease and Graves’ ophthalmopathy. Thyroid. 2008;18(11):1201–6. Epub 2008/10/18.
83.
Zurück zum Zitat Tsatsoulis A. The role of stress in the clinical expression of thyroid autoimmunity. Ann N Y Acad Sci. 2006;1088:382–95. Epub 2006/12/29. Tsatsoulis A. The role of stress in the clinical expression of thyroid autoimmunity. Ann N Y Acad Sci. 2006;1088:382–95. Epub 2006/12/29.
84.
Zurück zum Zitat Davies TF, Martin A, Concepcion ES, Graves P, Cohen L, Ben-Nun A. Evidence of limited variability of antigen receptors on intrathyroidal T cells in autoimmune thyroid disease. N Engl J Med. 1991;325(4):238–44.CrossRefPubMed Davies TF, Martin A, Concepcion ES, Graves P, Cohen L, Ben-Nun A. Evidence of limited variability of antigen receptors on intrathyroidal T cells in autoimmune thyroid disease. N Engl J Med. 1991;325(4):238–44.CrossRefPubMed
85.
Zurück zum Zitat Davies TF, Martin A, Concepcion ES, Graves P, Lahat N, Cohen WL, et al. Evidence for selective accumulation of intrathyroidal T lymphocytes in human autoimmune thyroid disease based on T cell receptor V gene usage. J Clin Invest. 1992;89(1):157–62.CrossRefPubMed Davies TF, Martin A, Concepcion ES, Graves P, Lahat N, Cohen WL, et al. Evidence for selective accumulation of intrathyroidal T lymphocytes in human autoimmune thyroid disease based on T cell receptor V gene usage. J Clin Invest. 1992;89(1):157–62.CrossRefPubMed
86.
Zurück zum Zitat Dayan CM, Londei M, Corcoran AE, Grubeck-Loebenstein B, James RF, Rapoport B, et al. Autoantigen recognition by thyroid-infiltrating T cells in Graves disease. Proc Natl Acad Sci USA. 1991;88(16):7415–9.CrossRefPubMed Dayan CM, Londei M, Corcoran AE, Grubeck-Loebenstein B, James RF, Rapoport B, et al. Autoantigen recognition by thyroid-infiltrating T cells in Graves disease. Proc Natl Acad Sci USA. 1991;88(16):7415–9.CrossRefPubMed
87.
Zurück zum Zitat Jackson RA, Haynes BF, Burch WM, Shimizu K, Bowring MA, Eisenbarth GS. Ia+ T cells in new onset Graves’ disease. J Clin Endocrinol Metab. 1984;59(2):187–90.CrossRefPubMed Jackson RA, Haynes BF, Burch WM, Shimizu K, Bowring MA, Eisenbarth GS. Ia+ T cells in new onset Graves’ disease. J Clin Endocrinol Metab. 1984;59(2):187–90.CrossRefPubMed
88.
Zurück zum Zitat Wall JR, Baur R, Schleusener H, Bandy-Dafoe P. Peripheral blood and intrathyroidal mononuclear cell populations in patients with autoimmune thyroid disorders enumerated using monoclonal antibodies. J Clin Endocrinol Metab. 1983;56(1):164–9.CrossRefPubMed Wall JR, Baur R, Schleusener H, Bandy-Dafoe P. Peripheral blood and intrathyroidal mononuclear cell populations in patients with autoimmune thyroid disorders enumerated using monoclonal antibodies. J Clin Endocrinol Metab. 1983;56(1):164–9.CrossRefPubMed
89.
Zurück zum Zitat Martin A, Nakashima M, Zhou A, Aronson D, Werner AJ, Davies TF. Detection of major T cell epitopes on human thyroid stimulating hormone receptor by overriding immune heterogeneity in patients with Graves’ disease. J Clin Endocrinol Metab. 1997;82(10):3361–6.CrossRefPubMed Martin A, Nakashima M, Zhou A, Aronson D, Werner AJ, Davies TF. Detection of major T cell epitopes on human thyroid stimulating hormone receptor by overriding immune heterogeneity in patients with Graves’ disease. J Clin Endocrinol Metab. 1997;82(10):3361–6.CrossRefPubMed
90.
Zurück zum Zitat Martin A, Barbesino G, Davies TF. T-cell receptors and autoimmune thyroid disease—signposts for T-cell-antigen driven diseases. Int Rev Immunol. 1999;18(1–2):111–40.CrossRefPubMed Martin A, Barbesino G, Davies TF. T-cell receptors and autoimmune thyroid disease—signposts for T-cell-antigen driven diseases. Int Rev Immunol. 1999;18(1–2):111–40.CrossRefPubMed
92.
Zurück zum Zitat Sakaguchi S. Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol. 2005;6(4):345–52.CrossRefPubMed Sakaguchi S. Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol. 2005;6(4):345–52.CrossRefPubMed
93.
Zurück zum Zitat McLachlan SM, Nagayama Y, Pichurin PN, Mizutori Y, Chen CR, Misharin A, et al. The link between Graves’ disease and Hashimoto’s thyroiditis: a role for regulatory T cells. Endocrinology. 2007;148(12):5724–33.CrossRefPubMed McLachlan SM, Nagayama Y, Pichurin PN, Mizutori Y, Chen CR, Misharin A, et al. The link between Graves’ disease and Hashimoto’s thyroiditis: a role for regulatory T cells. Endocrinology. 2007;148(12):5724–33.CrossRefPubMed
94.
Zurück zum Zitat Saitoh O, Nagayama Y. Regulation of Graves’ hyperthyroidism with naturally occurring CD4+ CD25+ regulatory T cells in a mouse model. Endocrinology. 2006;147(5):2417–22.CrossRefPubMed Saitoh O, Nagayama Y. Regulation of Graves’ hyperthyroidism with naturally occurring CD4+ CD25+ regulatory T cells in a mouse model. Endocrinology. 2006;147(5):2417–22.CrossRefPubMed
95.
Zurück zum Zitat Saitoh O, Abiru N, Nakahara M, Nagayama Y. CD8+ CD122+ T cells, a newly identified regulatory T subset, negatively regulate Graves’ hyperthyroidism in a murine model. Endocrinology. 2007;148(12):6040–6.CrossRefPubMed Saitoh O, Abiru N, Nakahara M, Nagayama Y. CD8+ CD122+ T cells, a newly identified regulatory T subset, negatively regulate Graves’ hyperthyroidism in a murine model. Endocrinology. 2007;148(12):6040–6.CrossRefPubMed
96.
Zurück zum Zitat Marazuela M, Garcia-Lopez MA, Figueroa-Vega N, de la FH, varado-Sanchez B, Monsivais-Urenda A, et al. Regulatory T cells in human autoimmune thyroid disease. J Clin Endocrinol Metab. 2006;91(9):3639–46. Marazuela M, Garcia-Lopez MA, Figueroa-Vega N, de la FH, varado-Sanchez B, Monsivais-Urenda A, et al. Regulatory T cells in human autoimmune thyroid disease. J Clin Endocrinol Metab. 2006;91(9):3639–46.
97.
Zurück zum Zitat Owen CJ, Eden JA, Jennings CE, Wilson V, Cheetham TD, Pearce SH. Genetic association studies of the FOXP3 gene in Graves’ disease and autoimmune Addison’s disease in the United Kingdom population. J Mol Endocrinol. 2006;37(1):97–104.CrossRefPubMed Owen CJ, Eden JA, Jennings CE, Wilson V, Cheetham TD, Pearce SH. Genetic association studies of the FOXP3 gene in Graves’ disease and autoimmune Addison’s disease in the United Kingdom population. J Mol Endocrinol. 2006;37(1):97–104.CrossRefPubMed
98.
Zurück zum Zitat Ban Y, Tozaki T, Tobe T, Jacobson EM, Concepcion ES, Tomer Y. The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: an association analysis in Caucasian and Japanese cohorts. J Autoimmun. 2007;28(4):201–7. Epub 2007/04/10. Ban Y, Tozaki T, Tobe T, Jacobson EM, Concepcion ES, Tomer Y. The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: an association analysis in Caucasian and Japanese cohorts. J Autoimmun. 2007;28(4):201–7. Epub 2007/04/10.
99.
Zurück zum Zitat Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441(7090):235–8.CrossRefPubMed Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441(7090):235–8.CrossRefPubMed
100.
Zurück zum Zitat Fossiez F, Djossou O, Chomarat P, Flores-Romo L, it-Yahia S, Maat C, et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med. 1996;183(6):2593–603. Fossiez F, Djossou O, Chomarat P, Flores-Romo L, it-Yahia S, Maat C, et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med. 1996;183(6):2593–603.
101.
Zurück zum Zitat Lubberts E, Joosten LA, van de Loo FA, Schwarzenberger P, Kolls J, Van Den Berg WB. Overexpression of IL-17 in the knee joint of collagen type II immunized mice promotes collagen arthritis and aggravates joint destruction. Inflamm Res. 2002;51(2):102–4.CrossRefPubMed Lubberts E, Joosten LA, van de Loo FA, Schwarzenberger P, Kolls J, Van Den Berg WB. Overexpression of IL-17 in the knee joint of collagen type II immunized mice promotes collagen arthritis and aggravates joint destruction. Inflamm Res. 2002;51(2):102–4.CrossRefPubMed
102.
Zurück zum Zitat Afzali B, Lombardi G, Lechler RI, Lord GM. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin ExpImmunol. 2007;148(1):32–46. Afzali B, Lombardi G, Lechler RI, Lord GM. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin ExpImmunol. 2007;148(1):32–46.
103.
Zurück zum Zitat Bohgaki T, Atsumi T, Koike T. Autoimmune disease after autologous hematopoietic stem cell transplantation. Autoimmun Rev. 2008;7(3):198–203.CrossRefPubMed Bohgaki T, Atsumi T, Koike T. Autoimmune disease after autologous hematopoietic stem cell transplantation. Autoimmun Rev. 2008;7(3):198–203.CrossRefPubMed
104.
Zurück zum Zitat Bohgaki T, Atsumi T, Koike T. Multiple autoimmune diseases after autologous stem-cell transplantation. N Engl J Med. 2007;357(26):2734–6.CrossRefPubMed Bohgaki T, Atsumi T, Koike T. Multiple autoimmune diseases after autologous stem-cell transplantation. N Engl J Med. 2007;357(26):2734–6.CrossRefPubMed
105.
Zurück zum Zitat Baker JR Jr. The nature of apoptosis in the thyroid and the role it may play in autoimmune thyroid disease. Thyroid. 2001;11(3):245–7.CrossRefPubMed Baker JR Jr. The nature of apoptosis in the thyroid and the role it may play in autoimmune thyroid disease. Thyroid. 2001;11(3):245–7.CrossRefPubMed
106.
Zurück zum Zitat Giordano C, Richiusa P, Bagnasco M, Salmaso C, Pizzolanti G, Galluzzo A. Thyrocytes–not innocent bystanders in autoimmune disease. Nat Immunol. 2001;2(3):183.CrossRefPubMed Giordano C, Richiusa P, Bagnasco M, Salmaso C, Pizzolanti G, Galluzzo A. Thyrocytes–not innocent bystanders in autoimmune disease. Nat Immunol. 2001;2(3):183.CrossRefPubMed
107.
Zurück zum Zitat Giordano C, Richiusa P, Bagnasco M, Pizzolanti G, Di BF, Sbriglia MS, et al. Differential regulation of Fas-mediated apoptosis in both thyrocyte and lymphocyte cellular compartments correlates with opposite phenotypic manifestations of autoimmune thyroid disease. Thyroid. 2001;11(3):233–44.CrossRefPubMed Giordano C, Richiusa P, Bagnasco M, Pizzolanti G, Di BF, Sbriglia MS, et al. Differential regulation of Fas-mediated apoptosis in both thyrocyte and lymphocyte cellular compartments correlates with opposite phenotypic manifestations of autoimmune thyroid disease. Thyroid. 2001;11(3):233–44.CrossRefPubMed
108.
Zurück zum Zitat Hamilton F, Black M, Farquharson MA, Stewart C, Foulis AK. Spatial correlation between thyroid epithelial cells expressing class II MHC molecules and interferon-gamma-containing lymphocytes in human thyroid autoimmune disease. Clin Exp Immunol. 1991;83(1):64–8.CrossRefPubMed Hamilton F, Black M, Farquharson MA, Stewart C, Foulis AK. Spatial correlation between thyroid epithelial cells expressing class II MHC molecules and interferon-gamma-containing lymphocytes in human thyroid autoimmune disease. Clin Exp Immunol. 1991;83(1):64–8.CrossRefPubMed
109.
Zurück zum Zitat Sawai Y, DeGroot LJ. Binding of human thyrotropin receptor peptides to a Graves’ disease-predisposing human leukocyte antigen class II molecule. J Clin Endocrinol Metab. 2000;85(3):1176–9.CrossRefPubMed Sawai Y, DeGroot LJ. Binding of human thyrotropin receptor peptides to a Graves’ disease-predisposing human leukocyte antigen class II molecule. J Clin Endocrinol Metab. 2000;85(3):1176–9.CrossRefPubMed
110.
Zurück zum Zitat McKenzie JM, Zakarija M. Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies. Thyroid. 1992;2(2):155–9.CrossRefPubMed McKenzie JM, Zakarija M. Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies. Thyroid. 1992;2(2):155–9.CrossRefPubMed
111.
Zurück zum Zitat Lira SA, Martin AP, Marinkovic T, Furtado GC. Mechanisms regulating lymphocytic infiltration of the thyroid in murine models of thyroiditis. Crit Rev Immunol. 2005;25(4):251–62.CrossRefPubMed Lira SA, Martin AP, Marinkovic T, Furtado GC. Mechanisms regulating lymphocytic infiltration of the thyroid in murine models of thyroiditis. Crit Rev Immunol. 2005;25(4):251–62.CrossRefPubMed
112.
Zurück zum Zitat Martin AP, Coronel EC, Sano G, Chen SC, Vassileva G, Canasto-Chibuque C, et al. A novel model for lymphocytic infiltration of the thyroid gland generated by transgenic expression of the CC chemokine CCL21. J Immunol. 2004;173(8):4791–8.PubMed Martin AP, Coronel EC, Sano G, Chen SC, Vassileva G, Canasto-Chibuque C, et al. A novel model for lymphocytic infiltration of the thyroid gland generated by transgenic expression of the CC chemokine CCL21. J Immunol. 2004;173(8):4791–8.PubMed
113.
Zurück zum Zitat Kita-Furuyama M, Nagayama Y, Pichurin P, McLachlan SM, Rapoport B, Eguchi K. Dendritic cells infected with adenovirus expressing the thyrotrophin receptor induce Graves’ hyperthyroidism in BALB/c mice. ClinExp Immunol. 2003;131(2):234–40.CrossRef Kita-Furuyama M, Nagayama Y, Pichurin P, McLachlan SM, Rapoport B, Eguchi K. Dendritic cells infected with adenovirus expressing the thyrotrophin receptor induce Graves’ hyperthyroidism in BALB/c mice. ClinExp Immunol. 2003;131(2):234–40.CrossRef
114.
Zurück zum Zitat Kabel PJ, Voorbij HA, De HM, van der Gaag RD, Drexhage HA. Intrathyroidal dendritic cells. J Clin Endocrinol Metab. 1988;66(1):199–207.CrossRefPubMed Kabel PJ, Voorbij HA, De HM, van der Gaag RD, Drexhage HA. Intrathyroidal dendritic cells. J Clin Endocrinol Metab. 1988;66(1):199–207.CrossRefPubMed
115.
Zurück zum Zitat Quadbeck B, Eckstein AK, Tews S, Walz M, Hoermann R, Mann K, et al. Maturation of thyroidal dendritic cells in Graves’ disease. Scand J Immunol. 2002;55(6):612–20.CrossRefPubMed Quadbeck B, Eckstein AK, Tews S, Walz M, Hoermann R, Mann K, et al. Maturation of thyroidal dendritic cells in Graves’ disease. Scand J Immunol. 2002;55(6):612–20.CrossRefPubMed
116.
Zurück zum Zitat Brigl M, Brenner MB. CD1: antigen presentation and T cell function. Annu Rev Immunol. 2004;22:817–90.CrossRefPubMed Brigl M, Brenner MB. CD1: antigen presentation and T cell function. Annu Rev Immunol. 2004;22:817–90.CrossRefPubMed
117.
Zurück zum Zitat Roura-Mir C, Catalfamo M, Cheng TY, Marqusee E, Besra GS, Jaraquemada D, et al. CD1a and CD1c activate intrathyroidal T cells during Graves’ disease and Hashimoto’s thyroiditis. J Immunol. 2005;174(6):3773–80.PubMed Roura-Mir C, Catalfamo M, Cheng TY, Marqusee E, Besra GS, Jaraquemada D, et al. CD1a and CD1c activate intrathyroidal T cells during Graves’ disease and Hashimoto’s thyroiditis. J Immunol. 2005;174(6):3773–80.PubMed
119.
Zurück zum Zitat Hutchings P, Rayner DC, Champion BR, Marshall-Clarke S, Macatonia S, Roitt I, et al. High efficiency antigen presentation by thyroglobulin-primed murine splenic B cells. Eur J Immunol. 1987;17(3):393–8.CrossRefPubMed Hutchings P, Rayner DC, Champion BR, Marshall-Clarke S, Macatonia S, Roitt I, et al. High efficiency antigen presentation by thyroglobulin-primed murine splenic B cells. Eur J Immunol. 1987;17(3):393–8.CrossRefPubMed
120.
Zurück zum Zitat Villanueva R, Inzerillo AM, Tomer Y, Barbesino G, Meltzer M, Concepcion ES, et al. Limited genetic susceptibility to severe Graves’ ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology. Thyroid. 2000;10(9):791–8. Epub 2000/10/21. Villanueva R, Inzerillo AM, Tomer Y, Barbesino G, Meltzer M, Concepcion ES, et al. Limited genetic susceptibility to severe Graves’ ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology. Thyroid. 2000;10(9):791–8. Epub 2000/10/21.
121.
Zurück zum Zitat Bahn RS. Graves’ ophthalmopathy. N Engl J Med. 2010;362(8):726–38. Epub 2010/02/26. Bahn RS. Graves’ ophthalmopathy. N Engl J Med. 2010;362(8):726–38. Epub 2010/02/26.
122.
Zurück zum Zitat Zhang L, Grennan-Jones F, Lane C, Rees DA, Dayan CM, Ludgate M. Adipose tissue depot-specific differences in the regulation of hyaluronan production of relevance to Graves' orbitopathy. J Clin Endocrinol Metab. 2012;97(2):653–62.CrossRefPubMed Zhang L, Grennan-Jones F, Lane C, Rees DA, Dayan CM, Ludgate M. Adipose tissue depot-specific differences in the regulation of hyaluronan production of relevance to Graves' orbitopathy. J Clin Endocrinol Metab. 2012;97(2):653–62.CrossRefPubMed
123.
Zurück zum Zitat Gerding MN, van der Meer JW, Broenink M, Bakker O, Wiersinga WM, Prummel MF. Association of thyrotrophin receptor antibodies with the clinical features of Graves’ ophthalmopathy. Clin Endocrinol (Oxf). 2000;52(3):267–71. Epub 2000/03/16. Gerding MN, van der Meer JW, Broenink M, Bakker O, Wiersinga WM, Prummel MF. Association of thyrotrophin receptor antibodies with the clinical features of Graves’ ophthalmopathy. Clin Endocrinol (Oxf). 2000;52(3):267–71. Epub 2000/03/16.
124.
Zurück zum Zitat Vannucchi G, Campi I, Bonomi M, Covelli D, Dazzi D, Curro N, et al. Rituximab treatment in patients with active Graves’ orbitopathy: effects on proinflammatory and humoral immune reactions. Clin Exp Immunol. 2010;161(3):436–43. Epub 2010/06/10. Vannucchi G, Campi I, Bonomi M, Covelli D, Dazzi D, Curro N, et al. Rituximab treatment in patients with active Graves’ orbitopathy: effects on proinflammatory and humoral immune reactions. Clin Exp Immunol. 2010;161(3):436–43. Epub 2010/06/10.
125.
Zurück zum Zitat Konuk O, Hondur A, Akyurek N, Unal M. Apoptosis in orbital fibroadipose tissue and its association with clinical features in Graves’ ophthalmopathy. Ocul Immunol Inflamm. 2007;15(2):105–11. Epub 2007/06/15. Konuk O, Hondur A, Akyurek N, Unal M. Apoptosis in orbital fibroadipose tissue and its association with clinical features in Graves’ ophthalmopathy. Ocul Immunol Inflamm. 2007;15(2):105–11. Epub 2007/06/15.
126.
Zurück zum Zitat Pritchard J, Horst N, Cruikshank W, Smith TJ. Igs from patients with Graves’ disease induce the expression of T cell chemoattractants in their fibroblasts. J Immunol. 2002;168(2):942–50.PubMed Pritchard J, Horst N, Cruikshank W, Smith TJ. Igs from patients with Graves’ disease induce the expression of T cell chemoattractants in their fibroblasts. J Immunol. 2002;168(2):942–50.PubMed
127.
Zurück zum Zitat Pritchard J, Han R, Horst N, Cruikshank WW, Smith TJ. Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves’ disease is mediated through the insulin-like growth factor I receptor pathway. J Immunol. 2003;170(12):6348–54.PubMed Pritchard J, Han R, Horst N, Cruikshank WW, Smith TJ. Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves’ disease is mediated through the insulin-like growth factor I receptor pathway. J Immunol. 2003;170(12):6348–54.PubMed
Metadaten
Titel
Delineating the autoimmune mechanisms in Graves’ disease
verfasst von
Syed A. Morshed
Rauf Latif
Terry F. Davies
Publikationsdatum
01.12.2012
Verlag
Springer-Verlag
Erschienen in
Immunologic Research / Ausgabe 1-3/2012
Print ISSN: 0257-277X
Elektronische ISSN: 1559-0755
DOI
https://doi.org/10.1007/s12026-012-8312-8

Weitere Artikel der Ausgabe 1-3/2012

Immunologic Research 1-3/2012 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Eingreifen von Umstehenden rettet vor Erstickungstod

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.